Financials

  • Market Capitalization 3 B
  • Employee 198
  • Founded 1983
  • CEO N/A
  • Website www.celldex.com
  • Headquarter Delaware, United States
  • FIGI BBG000FW8LZ9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.43
Relación precio/flujo de caja
2.89

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1673
ELVN
Enliven Therapeutics, Inc. - Common Stock
51.73 USD+1.69%+2.76%+21.69%+150.39%3.15 B USD
1686
VERA
Vera Therapeutics, Inc. - Class A Common Stock
43.13 USD+3.93%+0.30%+25.05%+45.02%3.10 B USD
1758
IRON
Disc Medicine, Inc. - Common Stock
75.01 USD-1.28%-4.80%+8.62%+29.35%2.87 B USD
1794
KOD
Kodiak Sciences Inc - Common Stock
43.26 USD+5.26%+13.96%+26.90%+790.12%2.71 B USD

Noticias